AR004965A1 - Procedimiento de preparacion de derivados de fenilimidazolidina - Google Patents
Procedimiento de preparacion de derivados de fenilimidazolidinaInfo
- Publication number
- AR004965A1 AR004965A1 ARP960105163A ARP960105163A AR004965A1 AR 004965 A1 AR004965 A1 AR 004965A1 AR P960105163 A ARP960105163 A AR P960105163A AR P960105163 A ARP960105163 A AR P960105163A AR 004965 A1 AR004965 A1 AR 004965A1
- Authority
- AR
- Argentina
- Prior art keywords
- radicals
- esterified
- alkyl
- alkenyl
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
La invencion tiene por objeto un procedimiento de preparacion de derivados de fenilimidazolidina de formula (I) en la que R1 y R2 son hidrogeno, halogeno,alquilo, alquenilo, alquinilo, alquiloxi, alqueniloxi, alquiniloxi fenilo, fenoxi, nitro,trifluormetilo, arilo, ciano, amino, monoalquilamino,dialquilamino o carboxi libre esterificado, amidificado o salidificado. R3 se escoge entre el atomo de hidrogeno y los radicales, alquilo, alquenilo,alquinilo, arilo y arilalquilo, estando todosestos radicales eventualmente sustituidos con uno o varios sustituyentes escogidos entre los atomos dehalogeno, lo radicales hidroxilo, eventualmente esterificado, eterificado o protegido, alcoxi, alqueniloxi, alquiniloxi, trifluorometilo,me rcapto, ciano,arilo, ariloxi, carboxi libre esterificado, amidificado o salificado, amino, mono, dialquilamino, ariltio y los radicales ciclicos que comprenden 3 a 4eslabones, estando ademas los radicales alquilo, alquenilo o alquinilo, eventualmente interrumpidos por uno o varios atomos de oxigeno, de nitrogeno ode azufre, estando todos los atomos de azufre eventualmente oxidados en forma de sulfoxido o de sulfona, estando ademas los radicales arilo y aralquiloeventualmentesustit uidos con un radical alquilo, alquenilo o alquinilo; R4 y R5 son o bien identicos o diferentes, representan un atomo de hidrogeno o unradical alquilo, eventualmente sustituido con uno o varios sustituyentes escogidos entre los atomosde halo geno, el radical hidroxilo, eventualmenteesterificado, esterificado o protegido y los radicales feniltio y alquiltio, en los que el atomo de azufre puede estar oxidado en forma de sulfoxido o sulfonay estando eventualmente sustituido con unoo varios radicales escogidos entre atomos de halogeno, y los radicales hidroxilo eventualmente esterificado,
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9513589A FR2741346B1 (fr) | 1995-11-16 | 1995-11-16 | Nouveau procede de preparation de derives phenylimidazolidine |
Publications (1)
Publication Number | Publication Date |
---|---|
AR004965A1 true AR004965A1 (es) | 1999-04-07 |
Family
ID=9484624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960105163A AR004965A1 (es) | 1995-11-16 | 1996-11-13 | Procedimiento de preparacion de derivados de fenilimidazolidina |
Country Status (29)
Country | Link |
---|---|
US (1) | US6107488A (es) |
EP (1) | EP0877738B1 (es) |
JP (1) | JP2000500150A (es) |
KR (1) | KR100466991B1 (es) |
CN (1) | CN1131219C (es) |
AR (1) | AR004965A1 (es) |
AT (1) | ATE240300T1 (es) |
AU (1) | AU718832B2 (es) |
BR (1) | BR9611573A (es) |
CA (1) | CA2235335A1 (es) |
CU (1) | CU22890A3 (es) |
CZ (1) | CZ144498A3 (es) |
DE (1) | DE69628203T2 (es) |
DK (1) | DK0877738T3 (es) |
EA (1) | EA002658B1 (es) |
ES (1) | ES2193271T3 (es) |
FR (1) | FR2741346B1 (es) |
HU (1) | HUP9904034A3 (es) |
IL (1) | IL124382A0 (es) |
MX (1) | MX9803730A (es) |
NO (1) | NO316514B1 (es) |
PL (1) | PL189697B1 (es) |
PT (1) | PT877738E (es) |
SI (1) | SI0877738T1 (es) |
TR (1) | TR199800865T2 (es) |
TW (1) | TW404942B (es) |
UA (1) | UA67720C2 (es) |
WO (1) | WO1997018197A1 (es) |
ZA (1) | ZA969442B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602004031881D1 (de) * | 2003-12-19 | 2011-04-28 | Univ California | Verfahren und materialien zur beurteilung von prostatakrebstherapien |
WO2005099693A2 (en) * | 2004-02-24 | 2005-10-27 | The Regents Of The University Of California | Methods and materials for assessing prostate cancer therapies and compounds |
US7709517B2 (en) * | 2005-05-13 | 2010-05-04 | The Regents Of The University Of California | Diarylhydantoin compounds |
DK2656842T3 (en) | 2006-03-27 | 2016-11-07 | Univ California | Androgen receptor MODULATOR FOR THE TREATMENT OF PROSTATE CANCER AND androgen receptor-ASSOCIATED DISEASES |
SG10201408699TA (en) | 2006-03-29 | 2015-02-27 | Univ California | Diarylthiohydantoin compounds |
UY31432A1 (es) | 2007-10-26 | 2009-05-29 | Compuestos de diarilhidantoina | |
WO2011029782A1 (en) | 2009-09-11 | 2011-03-17 | Bayer Schering Pharma Aktiengesellschaft | Substituted (heteroarylmethyl) thiohydantoins as anticancer drugs |
AU2010265775B2 (en) | 2009-09-15 | 2013-09-12 | Mylan Group | Copolymers, polymeric particles comprising said copolymers and copolymeric binders for radiation-sensitive coating compositions for negative-working radiation-sensitive lithographic printing plates |
MX355915B (es) | 2010-02-16 | 2018-05-04 | Aragon Pharmaceuticals Inc | Moduladores del receptor de androgenos y usos de los mismos. |
WO2011006265A2 (en) | 2010-09-14 | 2011-01-20 | Mylan Group | Copolymers for near-infrared radiation-sensitive coating compositions for positive-working thermal lithographic printing plates |
EA202190820A1 (ru) | 2012-09-26 | 2021-10-29 | Арагон Фармасьютикалз, Инк. | Антиандрогены для лечения неметастатического кастрационно-резистентного рака простаты |
JOP20200097A1 (ar) | 2013-01-15 | 2017-06-16 | Aragon Pharmaceuticals Inc | معدل مستقبل أندروجين واستخداماته |
TWI726969B (zh) | 2016-01-11 | 2021-05-11 | 比利時商健生藥品公司 | 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物 |
WO2019078920A1 (en) | 2017-10-16 | 2019-04-25 | Aragon Pharmaceuticals, Inc. | ANTI-ANDROGENS FOR THE TREATMENT OF NON-METASTATIC RESISTANT PROSTATE CANCER |
CN108218784A (zh) * | 2018-01-16 | 2018-06-29 | 吴江信凯医药科技有限公司 | 一种尼鲁米特的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4916937B1 (es) * | 1970-01-21 | 1974-04-25 | ||
JPS5136332B1 (es) * | 1970-12-09 | 1976-10-07 | ||
CH544491A (de) * | 1971-03-16 | 1973-11-30 | Ciba Geigy Ag | Herbizides Mittel |
MC1220A1 (fr) * | 1977-10-28 | 1979-07-20 | Hoffmann La Roche | Nouveaux derives d'imidazolidine |
JPS57197268A (en) * | 1981-05-29 | 1982-12-03 | Sumitomo Chem Co Ltd | Substituted phenylhydantoin derivative, its preparation, and herbicide containing the same as active ingredient |
JPS62298562A (ja) * | 1986-06-17 | 1987-12-25 | Nippon Kayaku Co Ltd | ブロモアニリン類の製造法 |
FR2656302B1 (fr) * | 1989-12-22 | 1992-05-07 | Roussel Uclaf | Nouveau procede de preparation de l'anandron et derives de l'anandron. |
US5411981A (en) * | 1991-01-09 | 1995-05-02 | Roussel Uclaf | Phenylimidazolidines having antiandrogenic activity |
FR2694290B1 (fr) * | 1992-07-08 | 1994-09-02 | Roussel Uclaf | Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant. |
-
1995
- 1995-11-16 FR FR9513589A patent/FR2741346B1/fr not_active Expired - Fee Related
-
1996
- 1996-11-05 TW TW085113495A patent/TW404942B/zh not_active IP Right Cessation
- 1996-11-11 ZA ZA9609442A patent/ZA969442B/xx unknown
- 1996-11-13 AR ARP960105163A patent/AR004965A1/es unknown
- 1996-11-14 DE DE69628203T patent/DE69628203T2/de not_active Expired - Fee Related
- 1996-11-14 PL PL96326491A patent/PL189697B1/pl not_active IP Right Cessation
- 1996-11-14 ES ES96938306T patent/ES2193271T3/es not_active Expired - Lifetime
- 1996-11-14 TR TR1998/00865T patent/TR199800865T2/xx unknown
- 1996-11-14 SI SI9630547T patent/SI0877738T1/xx unknown
- 1996-11-14 JP JP9518630A patent/JP2000500150A/ja not_active Ceased
- 1996-11-14 WO PCT/FR1996/001794 patent/WO1997018197A1/fr not_active Application Discontinuation
- 1996-11-14 DK DK96938306T patent/DK0877738T3/da active
- 1996-11-14 EP EP96938306A patent/EP0877738B1/fr not_active Expired - Lifetime
- 1996-11-14 IL IL12438296A patent/IL124382A0/xx not_active IP Right Cessation
- 1996-11-14 CZ CZ981444A patent/CZ144498A3/cs unknown
- 1996-11-14 CA CA002235335A patent/CA2235335A1/fr not_active Abandoned
- 1996-11-14 AT AT96938306T patent/ATE240300T1/de not_active IP Right Cessation
- 1996-11-14 EA EA199800378A patent/EA002658B1/ru not_active IP Right Cessation
- 1996-11-14 PT PT96938306T patent/PT877738E/pt unknown
- 1996-11-14 AU AU75773/96A patent/AU718832B2/en not_active Ceased
- 1996-11-14 BR BR9611573A patent/BR9611573A/pt not_active Application Discontinuation
- 1996-11-14 HU HU9904034A patent/HUP9904034A3/hu unknown
- 1996-11-14 KR KR10-1998-0703667A patent/KR100466991B1/ko not_active IP Right Cessation
- 1996-11-14 CN CN96199660A patent/CN1131219C/zh not_active Expired - Fee Related
- 1996-11-14 UA UA98052491A patent/UA67720C2/uk unknown
- 1996-11-14 US US09/068,846 patent/US6107488A/en not_active Expired - Fee Related
-
1998
- 1998-05-11 MX MX9803730A patent/MX9803730A/es unknown
- 1998-05-15 NO NO982237A patent/NO316514B1/no unknown
- 1998-05-18 CU CU1998059A patent/CU22890A3/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR004965A1 (es) | Procedimiento de preparacion de derivados de fenilimidazolidina | |
TR199903025T2 (xx) | 4-Fenilpiperidin bile�imleri. | |
NL350077I1 (nl) | Cyprosulfamide | |
CO5021135A1 (es) | Compuestos quimicos | |
CY1112130T1 (el) | Ενεργοποιητης για υποδοχεα δελτα αποκρινομενος σε πολλαπλασιαστη υπεροξειδιοσωματος | |
TR200002157T2 (tr) | Kimyasal bileşikler | |
CO5601018A2 (es) | Derivados de n-fenil-2-pirimidin-amina | |
AR006390A1 (es) | Derivados de lactama | |
AR016131A1 (es) | -oxazolidinonas triciclicamente substituidas, procedimientos para su preparacion, uso de dichos compuestos y medicamentos. | |
AR004195A1 (es) | Nuevos derivados de la 5-0 desosaminil-6-0-metil-eritronolida a, su procedimiento de preparacion, compuestos intermediarios, metodo de aplicacionde los mismos para la preparacion de productos biologicamente activos. | |
DE69705480T2 (de) | Verwendung von Oestrogenagonisten und -antagonisten zur Herstellung eines Medikaments zur Behandlung von Atherosklerose, unabhängig von Lipidsenkung | |
AR041027A1 (es) | Derivados de 1,2,3-triazol con actividad antimicrobiana particularmente fungicida | |
ES2192031T3 (es) | Nuevas amidas aromaticas, su procedimiento de preparacion y su aplicacion como medicamentos. | |
DE69728544D1 (de) | Totalsynthese von acylfulvenen mit antitumorwirkung | |
ES2081136T3 (es) | 3-ureido-benzodiazepinonas utiles como antagonistas de cck o de gastrina. | |
PA8483901A1 (es) | Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia disminuida | |
DK0807627T3 (da) | Anilidforbindelser som ACAT-inhibitorer | |
BR9902084A (pt) | Heterociclos. | |
AR015311A1 (es) | Compuestos diaril selenuros, composiciones farmaceuticas y composiciones cosmeticas que comprenden al menos uno de dichos compuestos y utilizacion de la composicion cosmetica | |
ES2037011T3 (es) | Procedimiento para la preparacion de nuevos derivados de benzofuran-2-il-imidazol. | |
ES2194696T3 (es) | Compuestos quimicos. | |
AR009452A1 (es) | Compuestos de dihalopropeno, los agentes insecticidas/acaricidas que los contienen y los intermediarios de sintesis de dichos compuestos. | |
DE60010276D1 (de) | Neuartige vitamin-d analoge | |
CO5011097A1 (es) | Derivados de 8-azabiciclo [3.2.1]octan-3-metanamina . | |
ES2190781T3 (es) | Derivados de 1-trifluorometil-4-hidroxi-7-piperidinil-aminometilcromano. |